|
1
|
Forner A, Llovet JM and Bruix J:
Hepatocellular carcinoma. Lancet. 379:1245–1255. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lee JI, Kim JK, Kim DY, Ahn SH, Park JY,
Kim SU, Kim BK, Han KH and Lee KS: Prognosis of hepatocellular
carcinoma patients with extrahepatic metastasis and the
controllability of intrahepatic lesions. Clin Exp Metastasis.
31:475–482. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nigro JM, Cho KR, Fearon ER, Kern SE,
Ruppert JM, Oliner JD, Kinzler KW and Vogelstein B: Scrambled
exons. Cell. 64:607–613. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen LL: The biogenesis and emerging roles
of circular RNAs. Nat Rev Mol Cell Biol. 17:205–211. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Meng S, Zhou H, Feng Z, Xu Z, Tang Y, Li P
and Wu M: CircRNA: Functions and properties of a novel potential
biomarker for cancer. Mol Cancer. 16:942017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang HD, Jiang LH, Sun DW, Hou JC and Ji
ZL: CircRNA: A novel type of biomarker for cancer. Breast Cancer.
25:1–7. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cui S, Qian Z, Chen Y, Li L, Li P and Ding
H: Screening of up- and downregulation of circRNAs in HBV-related
hepatocellular carcinoma by microarray. Oncol Lett. 15:423–432.
2018.PubMed/NCBI
|
|
10
|
Kou P, Zhang C, Lin J and Wang H: Circular
RNA hsa_circ_0078602 may have potential as a prognostic biomarker
for patients with hepatocellular carcinoma. Oncol Lett.
17:2091–2098. 2019.PubMed/NCBI
|
|
11
|
Nakamura M, Chiba T, Kanayama K, Hiroaki
Kanzaki H, Saito T, Kusakabe Y and Kato N: Epigenetic dysregulation
in hepatocellular carcinoma: An up-to-date review. Hepatol Res.
49:3–13. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lv Y, Wei W, Huang Z, Chen Z, Fang Y, Pan
L, Han X and Xu Z: Long non-coding RNA expression profile can
predict early recurrence in hepatocellular carcinoma after curative
resection. Hepatol Res. 48:1140–1148. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ma Y, Zhang C, Zhang B, Yu H and Yu Q:
circRNA of AR-suppressed PABPC1 91 bp enhances the cytotoxicity of
natural killer cells against hepatocellular carcinoma via
upregulating UL16 binding protein 1. Oncol Lett. 17:388–397.
2019.PubMed/NCBI
|
|
14
|
Xie B, Zhao Z, Liu Q, Wang X, Ma Z and Li
H: CircRNA has_circ_0078710 acts as the sponge of microRNA-31
involved in hepatocellular carcinoma progression. Gene.
683:253–261. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang XY, Huang ZL, Zhang PB, Huang XY,
Huang J, Wang HC, Xu B, Zhou J and Tang ZY: CircRNA-100338 is
associated with mTOR signaling pathway and poor prognosis in
hepatocellular carcinoma. Front Oncol. 9:3922019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hsu CM, Lin PM, Lin HC, Lai CC, Yang CH,
Lin SF and Yang MY: Altered expression of imprinted genes in
squamous cell carcinoma of the head and neck. Anticancer Res.
36:2251–2258. 2016.PubMed/NCBI
|
|
17
|
Vu TH and Hoffman AR: Promoter-specific
imprinting of the human insulin-like growth factor-II gene. Nature.
371:714–717. 1994. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livingstone C: IGF2 and cancer. Endocr
Relat Cancer. 20:R321–R339. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Brouwer-Visser J and Huang GS: IGF2
signaling and regulation in cancer. Cytokine Growth Factor Rev.
26:371–377. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tovar V, Alsinet C, Villanueva A, Hoshida
Y, Chiang DY, Solé M, Thung S, Moyano S, Toffanin S, Mínguez B, et
al: IGF activation in a molecular subclass of hepatocellular
carcinoma and pre-clinical efficacy of IGF-1R blockage. J Hepatol.
52:550–559. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Martinez-Quetglas I, Pinyol R, Dauch D,
Torrecilla S, Tovar V, Moeini A, Alsinet C, Portela A,
Rodriguez-Carunchio L, Solé M, et al: IGF2 is up-regulated by
epigenetic mechanisms in hepatocellular carcinomas and is an
actionable oncogene product in experimental models.
Gastroenterology. 151:1192–1205. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang C, Wu D, Gao L, Liu X, Jin Y, Wang D,
Wang T and Li X: Competing endogenous RNA networks in human cancer:
Hypothesis, validation, and perspectives. Oncotarget.
7:13479–13490. 2016.PubMed/NCBI
|
|
23
|
Qi X, Zhang DH, Wu N, Xiao JH, Wang X and
Ma W: ceRNA in cancer: Possible functions and clinical
implications. J Med Genet. 52:710–718. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Du H and Chen Y: Competing endogenous RNA
networks in cervical cancer: Function, mechanism, and perspective.
J Drug Target. 27:1–47. 2018.PubMed/NCBI
|
|
25
|
Han D, Li J, Wang H, Su X, Hou J, Gu Y,
Qian C, Lin Y, Liu X, Huang M, et al: Circular RNA circMTO1 acts as
the sponge of microRNA-9 to suppress hepatocellular carcinoma
progression. Hepatology. 66:1151–1164. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Barrett T, Wilhite SE, Ledoux P,
Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH,
Sherman PM, Holko M, et al: NCBI GEO: Archive for functional
genomics data sets--update. Nucleic Acids Res. 41(D1): D991–D995.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Smyth GK: Linear models and empirical
bayes methods for assessing differential expression in microarray
experiments. Stat Appl Genet Mol Biol. 3:Article32004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Turner DA: Miranda: A non-strict
functional language with polymorphic types. Proc. of a Conference
on Functional Programming Languages and Computer Architecture.
Jouannaud JP: Springer-Verlag; Berlin, Heidelberg: pp. 1–16. 1985,
View Article : Google Scholar
|
|
30
|
Jiang Q, Wang Y, Hao Y, Juan L, Teng M,
Zhang X, Li M, Wang G and Liu Y: miR2Disease: A manually curated
database for microRNA deregulation in human disease. Nucleic Acids
Res. 37:(Database). D98–D104. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
López-Terrada D, Cheung SW, Finegold MJ
and Knowles BB: Hep G2 is a hepatoblastoma-derived cell line. Hum
Pathol. 40:1512–1515. 2009. View Article : Google Scholar
|
|
33
|
Xu D, Yu J, Gao G, Lu G, Zhang Y and Ma P:
LncRNA DANCR functions as a competing endogenous RNA to regulate
RAB1A expression by sponging miR-634 in glioma. Biosci Rep.
38:BSR201716642018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhu RX, Seto WK, Lai CL and Yuen MF:
Epidemiology of hepatocellular carcinoma in the Asia-Pacific
region. Gut Liver. 10:332–339. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Salzman J, Chen RE, Olsen MN, Wang PL and
Brown PO: Cell-type specific features of circular RNA expression.
PLoS Genet. 9:e10037772013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Memczak S, Jens M, Elefsinioti A, Torti F,
Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer
M, et al: Circular RNAs are a large class of animal RNAs with
regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Salzman J, Gawad C, Wang PL, Lacayo N and
Brown PO: Circular RNAs are the predominant transcript isoform from
hundreds of human genes in diverse cell types. PLoS One.
7:e307332012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zatkova A, Rouillard JM, Hartmann W, Lamb
BJ, Kuick R, Eckart M, von Schweinitz D, Koch A, Fonatsch C,
Pietsch T, et al: Amplification and overexpression of the IGF2
regulator PLAG1 in hepatoblastoma. Genes Chromosomes Cancer.
39:126–137. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhen N, Gu S, Ma J, Zhu J, Yin M, Xu M,
Wang J, Huang N, Cui Z, Bian Z, et al: CircHMGCS1 promotes
hepatoblastoma cell proliferation by regulating the IGF signaling
pathway and glutaminolysis. Theranostics. 9:900–919. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Du WW, Yang W, Liu E, Yang Z, Dhaliwal P
and Yang BB: Foxo3 circular RNA retards cell cycle progression via
forming ternary complexes with p21 and CDK2. Nucleic Acids Res.
44:2846–2858. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Tay Y, Rinn J and Pandolfi PP: The
multilayered complexity of ceRNA crosstalk and competition. Nature.
505:344–352. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhang X, Luo P, Jing W, Zhou H, Liang C
and Tu J: circSMAD2 inhibits the epithelial-mesenchymal transition
by targeting miR-629 in hepatocellular carcinoma. OncoTargets Ther.
11:2853–2863. 2018. View Article : Google Scholar
|
|
44
|
Zhu Q, Lu G, Luo Z, Gui F, Wu J, Zhang D
and Yong Ni Y: CircRNA circ_0067934 promotes tumor growth and
metastasis in hepatocellular carcinoma through regulation of
miR-1324/FZD5/Wnt/β-catenin axis. Biochem Biophys Res Commun.
497:626–632. 2018. View Article : Google Scholar : PubMed/NCBI
|
